Vijay Bhargava, PhD
Vijay Bhargava is a Senior Advisor at Orange Grove Bio ("OGB"). He is currently a special advisor to several biotech firms advising them on Research and development strategies for the US/Global markets.
He was previously, the Corporate Executive Vice President and Global Head at Novartis Pharma. In addition, he was also the Research Site Head at the Novartis Institutes of Biomedical Research (NIBR) for the New Jersey site. His department contributed to Novartis R&D across the Globe.
He and his team were part of the development of several commercially successful medicines, but more importantly these medicines have helped improve the lives of millions of patients. He has lived and worked in India, Switzerland and US, gaining experience with global regulatory agencies.
Prior to joining Novartis in 2005, Vijay was Vice President and Global Head, Aventis Pharma.
He received his Ph.D. in pharmacokinetics and biopharmaceutics from Medical College of Virginia and went on to teach and supervise biopharmaceutics research as an Assistant Professor at the University of Nebraska Medical Center.
Vijay has contributed to numerous regulatory submissions for the approval of important medicines throughout his career. He has been involved in many innovative drug development programs. He has deep experience in R&D aspects of emerging market strategies.